71388-83-5

Basic information

• Product Name: Benzenepropanoic acid, 4-benzoyl-
• CAS NO: 71388-83-5
• Molecular Formula: C16H14O3
• Molecular Weight: 254.285
• Mol File: 71388-83-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzenepropanoic acid, 4-benzoyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenepropanoic acid, 4-benzoyl-(71388-83-5)
• EPA Substance Registry System: Benzenepropanoic acid, 4-benzoyl-(71388-83-5)

Safety Data

• Hazardous Substances Data: 71388-83-5(Hazardous Substances Data)

Upstream product

• 54411-77-7 methyl p-benzoyl-2,3-dihydrocinnamate 
• 3984-22-3 2-vinyl-1,3-dioxolane 
• 90-90-4 (4-bromophenyl)(phenyl)methanone 
• 98-88-4 benzoyl chloride 
• 103-25-3 3-phenylpropanoic acid methyl ester 
• 305839-15-0 methyl p-benzoyl-2,3-didehydrocinnamate 
• 305839-17-2 methyl (E)?3?(4?benzoylphenyl)acrylate 
• 6136-66-9 4-iodobenzophenone 

Downstream Products

• 89709-55-7 3-(4-Benzoyl-phenyl)-propionic acid (3S,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 
• 91176-07-7 3-(4-Benzoyl-phenyl)-propionic acid (3S,5S,6R,8S,9S,10R,13R,14S,17R)-3-acetoxy-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-6-yl ester 
• 91176-04-4 3-(4-Benzoyl-phenyl)-propionic acid (1aR,3aR,3bS,5aR,6R,8aS,8bS,10R,10aR)-6-((R)-1,5-dimethyl-hexyl)-3a,5a-dimethyl-hexadecahydro-cyclopenta[a]cyclopropa[2,3]cyclopenta[1,2-f]naphthalen-10-yl ester 
• 141396-92-1 3-(4-Benzoyl-phenyl)-propionic acid (2S,4aR,4bR,8aS,10aR)-4a,8a-dimethyl-tetradecahydro-phenanthren-2-yl ester 
• 141396-90-9 3-(4-Benzoyl-phenyl)-propionic acid (1R,2S,4aR,4bR,8aS,10aR)-1,4a,8a-trimethyl-tetradecahydro-phenanthren-2-yl ester 
• 141396-88-5 (1R,2S,4aR,4bS,8aR,10aR)-2-[3-(4-Benzoyl-phenyl)-propionyloxy]-1,4a-dimethyl-dodecahydro-phenanthrene-8a-carboxylic acid methyl ester 
• 141396-96-5 (1R,2S,4aR,8aR,10aR)-2-[3-(4-Benzoyl-phenyl)-propionyloxy]-1,4a-dimethyl-1,3,4,4a,6,7,8,9,10,10a-decahydro-2H-phenanthrene-8a-carboxylic acid methyl ester 
• 141397-03-7 (1R,2S,4aR,4bS,8aS,10aR)-2-[3-(4-Benzoyl-phenyl)-propionyloxy]-1,4a-dimethyl-6-oxo-dodecahydro-phenanthrene-8a-carboxylic acid methyl ester 
• 141397-02-6 C₃₆H₄₄O₇ 
• 89709-71-7 ω-(4-benzylphenyl)propionic acid 
• 128098-15-7 3-(4-benzoylphenyl)propanoyl chloride 
• 325708-78-9 2-(4-nitrophenyl)ethyl 6-{[3-(4-benzoylphenyl)-1-oxopropoxy]methyl}-2-{[(dimethylamino)methylene]amino}-3,4,5,6,7,8-hexahydro-4-oxopteridine-5-carboxylate 
• 325709-18-0 N-{5-[3-(4-benzoylphenyl)-1-oxopropyl]-3,4,5,6,7,8-hexahydro-4-oxopteridin-2-yl}-2-methylpropanamide 
• 720678-54-6 3-(4-Benzoyl-phenyl)-propionic acid (R)-11-{(2R,5R,2'R,5'R)-5'-[(1R,12R)-12-(tert-butyl-dimethyl-silanyloxy)-1-methoxymethoxy-13-((S)-5-methyl-2-oxo-2,5-dihydro-furan-3-yl)-tridecyl]-octahydro-[2,2']bifuranyl-5-yl}-11-methoxymethoxy-undecyl ester 

Relevant articles and documents

Structure-activity relationship of a new series of reversible dual monoacylglycerol lipase/fatty acid amide hydrolase inhibitors

The two endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), play independent and nonredundant roles in the body. This makes the development of both selective and dual inhibitors of their inactivation an important priority. In this work we report a new series of inhibitors of monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH). Among them, (±)-oxiran-2-ylmethyl 6-(1,1′-biphenyl-4-yl)hexanoate (8) and (2R)-(-)-oxiran-2-ylmethyl(4-benzylphenyl)acetate (30) stand out as potent inhibitors of human recombinant MAGL (IC50 (8) = 4.1 μM; IC 50 (30) = 2.4 μM), rat brain monoacylglycerol hydrolysis (IC 50 (8) = 1.8 μM; IC50 (30) = 0.68 μM), and rat brain FAAH (IC50 (8) = 5.1 μM; IC50 (30) = 0.29 μM). Importantly, and in contrast to the other previously described MAGL inhibitors, these compounds behave as reversible inhibitors either of competitive (8) or noncompetitive nature (30). Hence, they could be useful to explore the therapeutic potential of reversible MAGL inhibitors.

Synthesis of photoaffinity derivatives of adenophostin A

Photoaffinity derivatives 7 and 8 of adenophostin A, modified at the 5'- and 1'-positions, were prepared by a chemoselective reaction of the aminophostins 15 and 30 with N-succini-midyl p-benzoyl-2,3-dihydrocinnamate (p-benzoyldihydrocinnamoyl-N-hydroxysu

Liquid Crystalline Properties of Cholesteryl ω-Arylalkanoates

The thermal properties of the homologous series of cholesteryl ω-(4-benzoylphenyl)- (I), ω-(4-benzylphenyl)- (II), ω-benzoyl- (III), and ω-phenoxyalkanoate (IV) have been investigated.For series I and II the cholesteric-isotropic (Ch-I) transition temperatures, enthalpies, and entropies show a remarkable alternation.For series III and IV, the transition temperatures, enthalpies, and entropies exhibit weak alternation and their trends are opposite to those for series I and II, and the cholesteryl ω-phenylalkanoates.The cholesteric-isotropic transition temperatures are discussed in terms of the geometrical and electrical alternations stemming from the terminal aryl groups, and also the relative importance between these two terms.